UBS Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Sell |
126,160
-260,919
| -67% | -$2.46M | ﹤0.01% | 4217 |
|
2025
Q1 | $2.1M | Sell |
387,079
-182,947
| -32% | -$992K | ﹤0.01% | 3663 |
|
2024
Q4 | $4.25M | Buy |
570,026
+168,867
| +42% | +$1.26M | ﹤0.01% | 3119 |
|
2024
Q3 | $3.21M | Buy |
401,159
+211,256
| +111% | +$1.69M | ﹤0.01% | 2646 |
|
2024
Q2 | $1.65M | Sell |
189,903
-266,723
| -58% | -$2.32M | ﹤0.01% | 3008 |
|
2024
Q1 | $9.44M | Sell |
456,626
-117,543
| -20% | -$2.43M | ﹤0.01% | 1649 |
|
2023
Q4 | $13.3M | Buy |
574,169
+47,321
| +9% | +$1.09M | ﹤0.01% | 1306 |
|
2023
Q3 | $4.21M | Buy |
526,848
+437,190
| +488% | +$3.49M | ﹤0.01% | 1992 |
|
2023
Q2 | $780K | Buy |
89,658
+88,958
| +12,708% | +$774K | ﹤0.01% | 3489 |
|
2023
Q1 | $2.06K | Hold |
700
| – | – | ﹤0.01% | 7494 |
|
2022
Q4 | $2.45K | Buy |
700
+100
| +17% | +$350 | ﹤0.01% | 8480 |
|
2022
Q3 | $5K | Hold |
600
| – | – | ﹤0.01% | 8084 |
|
2022
Q2 | $5K | Sell |
600
-924
| -61% | -$7.7K | ﹤0.01% | 7823 |
|
2022
Q1 | $18K | Sell |
1,524
-30,828
| -95% | -$364K | ﹤0.01% | 6526 |
|
2021
Q4 | $396K | Buy |
32,352
+31,336
| +3,084% | +$384K | ﹤0.01% | 4155 |
|
2021
Q3 | $10K | Sell |
1,016
-730
| -42% | -$7.19K | ﹤0.01% | 6850 |
|
2021
Q2 | $16K | Buy |
1,746
+1,245
| +249% | +$11.4K | ﹤0.01% | 6476 |
|
2021
Q1 | $5K | Buy |
501
+1
| +0.2% | +$10 | ﹤0.01% | 7272 |
|
2020
Q4 | $3K | Sell |
500
-137,127
| -100% | -$823K | ﹤0.01% | 6962 |
|
2020
Q3 | $72K | Buy |
137,627
+31,252
| +29% | +$16.4K | ﹤0.01% | 4558 |
|
2020
Q2 | $81K | Buy |
106,375
+71,943
| +209% | +$54.8K | ﹤0.01% | 4647 |
|
2020
Q1 | $35K | Sell |
34,432
-52,787
| -61% | -$53.7K | ﹤0.01% | 5208 |
|
2019
Q4 | $135K | Buy |
87,219
+50,637
| +138% | +$78.4K | ﹤0.01% | 4829 |
|
2019
Q3 | $66K | Buy |
36,582
+30,196
| +473% | +$54.5K | ﹤0.01% | 5095 |
|
2019
Q2 | $11K | Sell |
6,386
-38,814
| -86% | -$66.9K | ﹤0.01% | 6129 |
|
2019
Q1 | $81K | Sell |
45,200
-8,151
| -15% | -$14.6K | ﹤0.01% | 4430 |
|
2018
Q4 | $101K | Buy |
53,351
+10,562
| +25% | +$20K | ﹤0.01% | 4657 |
|
2018
Q3 | $153K | Sell |
42,789
-3,221
| -7% | -$11.5K | ﹤0.01% | 4406 |
|
2018
Q2 | $95K | Buy |
46,010
+43,682
| +1,876% | +$90.2K | ﹤0.01% | 4599 |
|
2018
Q1 | $3K | Sell |
2,328
-13,242
| -85% | -$17.1K | ﹤0.01% | 6521 |
|
2017
Q4 | $17K | Buy |
15,570
+13,820
| +790% | +$15.1K | ﹤0.01% | 5700 |
|
2017
Q3 | $2K | Sell |
1,750
-1,400
| -44% | -$1.6K | ﹤0.01% | 6540 |
|
2017
Q2 | $5K | Buy |
3,150
+1,400
| +80% | +$2.22K | ﹤0.01% | 6162 |
|
2017
Q1 | $3K | Buy |
1,750
+579
| +49% | +$993 | ﹤0.01% | 6237 |
|
2016
Q4 | $2K | Buy |
+1,171
| New | +$2K | ﹤0.01% | 6509 |
|
2015
Q4 | – | Sell |
-393
| Closed | -$1K | – | 6903 |
|
2015
Q3 | $1K | Buy |
+393
| New | +$1K | ﹤0.01% | 6695 |
|
2015
Q1 | – | Sell |
-6,510
| Closed | -$27K | – | 6701 |
|
2014
Q4 | $27K | Buy |
+6,510
| New | +$27K | ﹤0.01% | 5237 |
|